Duo Oncology

About:

Duo Oncology develops a new nanoparticle technology specially tailored to penetrate established tumors.

Website: https://www.duooncology.com/

Twitter/X: DuoOncology

Top Investors: Innovation Works, BeiGene, LifeX Labs, Ulu Ventures, NuFund Venture Group

Description:

Duo Oncology develops a new nanoparticle technology specially tailored to penetrate established tumors. Duo Oncology operates as a lean pharma business. The company works hand-in-hand with world-class university scientists and medical oncologists to develop their products through a network of established research organizations with the greatest possible speed and efficiency.

Total Funding Amount:

$3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pittsburgh, Pennsylvania, United States

Founded Date:

2020-01-01

Founders:

Sam Rothstein

Number of Employees:

11-50

Last Funding Date:

2023-02-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai